Spots Global Cancer Trial Database for capeox
Every month we try and update this database with for capeox cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers | NCT05833672 | Colon Cancer Immunotherapy | Terelizumab CapeOx | 18 Years - 80 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer | NCT05576480 | Rectal Cancer Locally Advance... | Short-course ra... Penpulimab CAPEOX TME surgery | 18 Years - 75 Years | Ruijin Hospital | |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | NCT05394740 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | Regorafenib Nivolumab CapeOX FOLFOX regimen | 20 Years - | National Cancer Center Hospital East | |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | NCT05394740 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | Regorafenib Nivolumab CapeOX FOLFOX regimen | 20 Years - | National Cancer Center Hospital East | |
| Apatinib for Resectable Colorectal Cancer | NCT03228043 | Apatinib Outcome, Fatal Colorectal Canc... Surgery Adjuvant Chemot... | Apatinib CAPEOX | 18 Years - 75 Years | Nanchong Central Hospital | |
| Apatinib for Resectable Colorectal Cancer | NCT03228043 | Apatinib Outcome, Fatal Colorectal Canc... Surgery Adjuvant Chemot... | Apatinib CAPEOX | 18 Years - 75 Years | Nanchong Central Hospital | |
| Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers | NCT05833672 | Colon Cancer Immunotherapy | Terelizumab CapeOx | 18 Years - 80 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer | NCT04620473 | Neoadjuvant Tre... Rectal Cancer Anlotinib | Anlotinib+Capeo... Capeox | 18 Years - 75 Years | Shanghai Minimally Invasive Surgery Center | |
| Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | NCT06014372 | Colon Cancer Neoadjuvant The... Immunotherapy | Envafolimab CAPEOX | 18 Years - 75 Years | Sun Yat-sen University | |
| A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx | NCT05068206 | Unresectable Me... | AK105 injection Anlotinib hydro... CapeOX Bevacizumab | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | NCT06014372 | Colon Cancer Neoadjuvant The... Immunotherapy | Envafolimab CAPEOX | 18 Years - 75 Years | Sun Yat-sen University | |
| Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | NCT00387387 | Neoplasms, Colo... | Pazopanib FOLFOX 6 CapeOx | 21 Years - | GlaxoSmithKline | |
| Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | NCT06014372 | Colon Cancer Neoadjuvant The... Immunotherapy | Envafolimab CAPEOX | 18 Years - 75 Years | Sun Yat-sen University | |
| Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | NCT05201430 | Rectal Cancer | FOLFOXIRI CapeOX | 18 Years - 75 Years | Fudan University | |
| Apatinib for Resectable Colorectal Cancer | NCT03228043 | Apatinib Outcome, Fatal Colorectal Canc... Surgery Adjuvant Chemot... | Apatinib CAPEOX | 18 Years - 75 Years | Nanchong Central Hospital | |
| Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer | NCT05731726 | pMMR MSS MSI-L Locally Advance... | Serplilumab Capecitabine Oxaliplatin Celecoxib | 18 Years - 75 Years | Zhejiang University | |
| Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | NCT06014372 | Colon Cancer Neoadjuvant The... Immunotherapy | Envafolimab CAPEOX | 18 Years - 75 Years | Sun Yat-sen University | |
| Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors | NCT05515796 | Immunotherapy Gastric Cancer Rectal Cancer Chemotherapy Ef... Radiotherapy | Terelizumab (ak... CapeOx Trastuzumab Radiotherapy | 19 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers | NCT05833672 | Colon Cancer Immunotherapy | Terelizumab CapeOx | 18 Years - 80 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors | NCT05515796 | Immunotherapy Gastric Cancer Rectal Cancer Chemotherapy Ef... Radiotherapy | Terelizumab (ak... CapeOx Trastuzumab Radiotherapy | 19 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | NCT05394740 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | Regorafenib Nivolumab CapeOX FOLFOX regimen | 20 Years - | National Cancer Center Hospital East | |
| Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | NCT00387387 | Neoplasms, Colo... | Pazopanib FOLFOX 6 CapeOx | 21 Years - | GlaxoSmithKline | |
| Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer | NCT05731726 | pMMR MSS MSI-L Locally Advance... | Serplilumab Capecitabine Oxaliplatin Celecoxib | 18 Years - 75 Years | Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
